ALLO
Allogene Therapeutics Inc
1.70$
+0.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -300.0% | – | -100.0% | – | – | – | – | – | – | – | – | – | |
| – | -2.7% | +2.2% | +1,316.5% | -11.2% | -92.8% | -4.1% | +1,195.8% | -22.4% | -90.2% | -6.1% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +18.9% | -4.4% | -3.6% | -11.2% | +0.6% | +11.6% | -20.0% | -22.4% | -8.1% | +1.8% | +5.4% | – | |
| – | +1.1% | +0.2% | -6.8% | +1.5% | -5.0% | -3.4% | -4.7% | -3.8% | +0.3% | +2.3% | +47.9% | – | |
| – | +43.2% | -22.5% | -68.1% | +28.4% | +111.6% | +8.4% | -73.2% | -17.6% | +186.4% | +9.9% | +19.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -100.0% | – | – | -19.0% | +85.2% | +78.7% | +28.4% | -9.0% | -4.2% | +14.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -100.0% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.